CLENE NANOMEDICINE, INC. – Trademark Portfolio
Entity Type: 03
CLENE NANOMEDICINE, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include CSN, CNM-AU8, AUVANEGY, and CLENE NANOMEDICINE. The owner is based in SALT LAKE CITY, UT.
SUITE 325
3165 MILLROCK DRIVE
SALT LAKE CITY, UT 84121
Showing of trademarks Trademarks
Trademark Classifications
CLENE NANOMEDICINE, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does CLENE NANOMEDICINE, INC. have?
CLENE NANOMEDICINE, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 abandoned.
What trademark classes does CLENE NANOMEDICINE, INC. file in?
CLENE NANOMEDICINE, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CLENE NANOMEDICINE, INC.'s most well-known trademarks?
CLENE NANOMEDICINE, INC.'s registered trademark portfolio includes well-known marks such as CSN, CNM-AU8, AUVANEGY, and CLENE NANOMEDICINE. These are among 4 currently registered trademarks in the portfolio.
What is CLENE NANOMEDICINE, INC.'s trademark registration success rate?
CLENE NANOMEDICINE, INC. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.